This cutting edge unit focuses on research and treatment using celluar therapies to treat cancer. The project includes a 14 bay hemapheresis patient unit directly adjacent to a Cell Therapy research laboratory suite. The unit supports the research and production of 361 and 351 HCT/P products including HPC apheresis, cord,marrow and a variety of more than minimally manipulated cellular products. Within the design for Cell Therapy suite are six (6) ISO7 labs, anterooms, airlocks, and cryogenic storage facility, which underwent an extensive review with the FDA for approval.